Question 1

What is Novaqis Technologies?

Accepted Answer

Novaqis Technologies is a software company building a modular suite for regulated operations. Admin covers identity, organizations, and licensing; DMS delivers GxP document management and electronic records; Reporting provides operational insight without shadow exports; and Nova AI is our self-developed AI agent layer (not third-party cloud “Nova” products) for OCR, human language to SQL, real-time custom reports from the Reporting datalake, on-demand analysis, fast Q&A, and more—including offline-capable deployment where required—all under unified governance and access rules across the stack. The company is based in Vadodara, India, and has been actively building the platform since 2025.

The company was founded by Ashutosh Biswal, who brings roughly eight years of industry experience. Novaqis exists to address a gap we kept seeing in the market: unstable or insecure implementations, dated user experiences on top of legacy stacks, and high total cost for value that should be defensible in audit and pleasant to run day to day. The goal is not noise—it is a production-grade, modern alternative teams can validate and operate with confidence.

Question 2

What is Nova AI and what can it do?

Accepted Answer

Nova AI is Novaqis’s self-developed AI agent—not Amazon Nova or other vendors’ cloud chat products. It can run offline where your environment requires it. Capabilities include high-accuracy OCR for documents and scans; human language to SQL; real-time custom reports from the Reporting datalake; analysis and summaries grounded in your governed data; a chatbot that returns answers in seconds; and more on the roadmap. Access and data scope always follow your security and segregation-of-duties rules.

Question 3

Is Novaqis a good DMS for pharmaceutical companies?

Accepted Answer

Novaqis DMS is built for pharmaceutical and biotech quality use cases: controlled documents, workflows, signatures, and auditability, with design themes aligned to 21 CFR Part 11 and EU Annex 11. Suitability always depends on your validation strategy and SOPs—we recommend a guided evaluation and, where needed, IQ/OQ/PQ in your environment.

Question 4

Can cosmetic or personal-care manufacturers use Novaqis?

Accepted Answer

Yes. Cosmetic and personal care firms under GMP-style quality systems often need the same document control, training, and audit trail rigor as pharma—at appropriate scale. DMS and Admin support those patterns; we can discuss scope during presales.

Question 5

Does Novaqis support 21 CFR Part 11-style electronic records?

Accepted Answer

Novaqis DMS is engineered with Part 11–relevant capabilities in mind (e.g. electronic records, signatures, traceability). Compliance is always a shared responsibility: your organization validates the system in context and maintains procedures. We do not claim automatic regulatory approval.

Question 6

Which industries is Novaqis built for?

Accepted Answer

The platform targets pharmaceutical, biotech, cosmetic GMP, and other regulated sectors that need strong audit trails and segregation of duties—not generic file sharing.

Question 7

We are evaluating several validated DMS vendors—how should we look at Novaqis?

Accepted Answer

Treat Novaqis as a peer competitor on the same shortlist—not a niche side tool. Compare deployment (your cloud or data center), functional fit for SOPs and Part 11 scope, workflows, electronic signatures, integration with identity and reporting, and total cost of ownership. We expect side-by-side evaluations and welcome deep technical due diligence.

Question 8

Is Novaqis an alternative to Veeva Vault, Caliber / Docs IQ, or other enterprise pharma DMS platforms?

Accepted Answer

Yes—in the sense that we compete in the same buying decisions. Teams that evaluate regulated document management, GxP content repositories, or quality document suites (including offerings such as Veeva Vault, Caliber and related Docs IQ capabilities, MasterControl, OpenText Documentum, or similar platforms) should include Novaqis for a fair comparison. We are a separate product from those vendors and not affiliated with them; naming them is nominative—to identify the category of solutions buyers compare—not to imply endorsement. Any preference we express elsewhere on the site is our opinion; your POC and validation should drive the decision. All third-party names are trademarks of their respective owners.

Question 9

Can we deploy on our own infrastructure?

Accepted Answer

Yes. Novaqis is intended to run inside your perimeter—on-premises or in your cloud—so data residency and security controls stay under your governance. Exact topology depends on your validation and IT standards.

Question 10

Do we have to use all products?

Accepted Answer

No. Each core product (Admin, DMS, Reporting) can be licensed and activated according to your needs. Nova AI may be adopted as an add-on intelligent layer depending on your rollout; it shares the same governance mindset. They work cohesively when you use more than one.

Question 11

How does licensing work?

Accepted Answer

Novaqis uses offline asymmetric license verification (V1 signed envelopes). Your deployment receives a license bound to a stable server identifier and instance (e.g. Production vs Training). Activation is verified by Admin using public keys you configure.

Question 12

How do I get sales or technical help?

Accepted Answer

Use the enquiry form on this site, open live chat (email + thread with our team when staffed), or email contact@novaqis.com. For partners, Partner studio remains available for internal license operations.

Question 13

Is Novaqis validated out of the box?

Accepted Answer

Software is provided as a GxP-oriented system; your organization performs IQ/OQ/PQ (or equivalent) in your environment. We can discuss documentation expectations and deployment models during presales.

Question 14

What does the Reporting product cover?

Accepted Answer

Reporting focuses on operational and lifecycle-oriented analytics and event flows suitable for regulated reporting scenarios, integrated with the rest of the suite where configured.

Frequently asked questions

General

Products

Deployment

Licensing

Frequently asked questions

General

Products

Deployment

Licensing